Skip to main content

DRDO's 2-DG Gets DCGI Approval | INMAS develops anti-covid therapeutic application of 2-deoxy-D-glucose drug

Image
By

 DRDO's 2-DG Gets DCGI Approval | INMAS Develops Anti-Covid Therapeutic Application of 2-Deoxy-D-Glucose Drug


DRDO's anti-Covid drug 2-DG

The anti-COVID-19 therapeutic has been developed by DRDO scientists at the Institute of Nuclear Medicine and Allied Sciences (INMAS).

The Drugs Controller General of India (DCGI), a body responsible for approval of licences of drugs in India, has approved the anti-COVID-19 therapeutic developed by Defence Ministry's  Defence Research and Development Organisation (DRDO). The drug, which received the emergency use authorisation on May 1, is called 2-deoxy-D-glucose (2-DG). According to a press release by the Defence Ministry, clinical trials of 2-DG have demonstrated that it helps in faster recovery of patients severely ill with the COVID-19 disease. The drug helps in faster recovery of hospitalised patients by reducing their dependency on oxygen, which can come in handy in these trying times when the country is suffering from an acute shortage of oxygen concentrators. 

Know everything about DRDO's 2-DG drug

The anti-COVID-19 therapeutic has been developed by DRDO scientists at the Institute of Nuclear Medicine and Allied Sciences (INMAS). The drug has been developed in collaboration between DRDO and Dr Reddy’s Laboratories (DRL) in Hyderabad. The drug was ready for clinical trials in April last year after DRDO and INMAS scientists conducted experiments inside the lab and found 2-DG to be safe and effective against the SARS-CoV-2 virus.

Based on the results from the lab experiment, DCGI permitted DRDO to conduct Phase-II clinical trials of the drug. The trials showed 2-DG was effective against the COVID-19 virus and demonstrated signs of recovery in patients. Following the successful Phase-II trials between May and October 2020, the drug was tested again in Phase-IIa and Phase-IIb trials, which were conducted at six and 11 hospitals respectively. Overall the Phase-II trials were conducted on 110 patients. 

The DRDO received approval to conduct Phase-III trials of the drug by DCGI in November 2020. The Phase-II trials were conducted between December 2020-March 2021 at 27 hospitals across India, including in Delhi, Uttar Pradesh, West Bengal, Maharashtra, Gujarat, Tamil Nadu, Telangana, Karnataka, etc. The Phase-III trials were conducted on 220 patients. The results showed faster recovery in patients who took the drug as compared to those who followed just the Standard of Care (SoC). The use of oxygen in patients who took 2-DG declined significantly. 

How to take the drug?

2-DG comes in powder form, which the infected patients can take orally by mixing up the drug in water. The drug, which is akin to a glucose mix, is easy to manufacture and store, which makes it critical at a time when many people are dying because of the lack of oxygen infrastructure for supply and transportation in India. 



New Source : https://www.republicworld.com/india-news/general-news/drdos-2-dg-gets-dcgi-approval-heres-all-you-need-to-know-about-the-anti-covid-19-drug.html


Comments

Post a Comment

Popular posts from this blog

Reforming Hair Loss Treatment With Stem Cells

By
Losing hair can be very frustrating and insulting, and for years, people have been looking for different methods to treat hair loss effectively. Presently, people mainly rely on hair transplant to treat hair loss problem. However, things are going to change for the better in the near future, with the advent of stem cell therapy for Hair Loss Treatment . Research and tests suggest that this can be a very viable treatment to cure hair loss. The procedure is non-surgical and it helps in stimulating and re-growing the hair follicles. The existing methods vs. the new method of hair loss treatment On one hand where the existing methods of Hair Loss Treatment depends on transplantation of hair follicles from one section to another section of your head, the stem cell therapy, on the other hand, provides an infinite source of stem cells taken from the patient. There is no limitation as far as availability of hair follicles is concerned. This kind of treatment will be the most benefi...
1 comment
Read more

Know About ​Mesenchymal stem cells (MSCs)

By
 Know About ​Mesenchymal stem cells (MSCs) ​Mesenchymal stem cells (MSCs) are a type of adult stem cell found in several tissues in the body, including bone marrow, adipose tissue, and umbilical cord tissue. They have the ability to differentiate into multiple cell types, such as osteoblasts, chondrocytes, and adipocytes, which are responsible for bone, cartilage, and fat tissue formation, respectively. MSCs have gained significant attention in recent years due to their potential use in regenerative medicine. They have the ability to secrete various growth factors and cytokines that promote tissue repair and regeneration. Additionally, they have immunomodulatory properties that make them attractive candidates for treating autoimmune diseases and reducing inflammation. MSCs have been used in various preclinical and clinical trials to treat a wide range of conditions, including osteoarthritis, cardiovascular disease, and neurological disorders, among others. They can be isolated from...
Post a Comment
Read more

Stem Cell Therapy for Liver Cirrhosis

By
 Stem Cell Therapy for Liver Cirrhosis Stem cell therapy is a promising area of research for the treatment of liver cirrhosis. Liver cirrhosis is a progressive condition in which the liver becomes scarred and damaged, leading to a loss of liver function. This can be caused by a variety of factors, including chronic alcohol abuse, viral hepatitis, and non-alcoholic fatty liver disease. Stem cells have the potential to regenerate damaged tissues and organs, including the liver. In the case of liver cirrhosis, stem cells can differentiate into liver cells and promote the growth of healthy tissue, thereby restoring liver function. Web: https://www.giostar.com/Therapy/liver-diseases/ Email: stemcells@giostar.com GIOSTAR Ahmedabad:  +91-7043008890 GIOSTAR Bangalore: +91-6366209990 GIOSTAR Chandigarh: +91-9501768105 #STEM #stemcells #therapy #liver #cirrhosis #giostar #livercirrhosis #liverdisease #giostarindia
Post a Comment
Read more